Botox® 100 Units | Allergan Aesthetics (OnabotulinumtoxinA)

Short Description

The global gold standard in neuromodulator therapy, Botox® by Allergan Aesthetics (an AbbVie company) is the most researched and clinically validated Botulinum Toxin Type A formulation in aesthetic medicine. Engineered with a proprietary 900 kDa molecular complex, it provides unmatched precision, predictable localized diffusion, and peer-reviewed safety for dynamic facial line correction and therapeutic indications.

Detailed Description

Botox® (OnabotulinumtoxinA) is the benchmark injectable neuromodulator worldwide, supported by more than 30 years of clinical application and over 500 peer-reviewed scientific articles. Produced via proprietary fermentation and purification protocols, each vial contains a uniform, vacuum-dried formulation of Clostridium botulinum type A neurotoxin complexed with protective hemagglutinin and non-toxic non-hemagglutinin proteins.

By cleaving SNAP-25 within the presynaptic nerve terminal, Botox® temporarily impedes the exocytosis of acetylcholine at the neuromuscular junction. This controlled neuro-relaxation smooths hyperdynamic lines and contours the facial architecture while maintaining predictable dosing profiles and natural tissue dynamics.

Treatment Areas & Indications

• Upper Facial Aesthetics:

  • Moderate-to-severe glabellar lines (frown lines between the brows)

  • Lateral canthal lines (crow’s feet)

  • Horizontal forehead rhytids

• Mid-to-Lower Face & Neck Sculpting:

  • Masseter muscle hypertrophy (jawline contouring and bruxism management)

  • Depressor Anguli Oris (DAO) modulation to correct downturned mouth corners

  • Mentalis smoothing (chin dimpling / “peau d’orange”)

  • Platysmal bands and jawline definition (Nefertiti Lift)

  • Bunny lines (transverse nasal lines)

• Therapeutic & Dermatology Applications:

  • Severe primary axillary and palmar hyperhidrosis

  • Chronic migraine prophylaxis

  • Blepharospasm and hemifacial spasm

Key Clinical Advantages

• The 900 kDa Standard: The heavy molecular weight complex provides a controlled, localized field of effect with minimal lateral migration, protecting adjacent non-target musculature.

• Batch-to-Batch Uniformity: Rigorous biological potency assays ensure consistent therapeutic potency across every manufactured lot.

• Unmatched Clinical Backing: Holds extensive approvals from the US FDA, EMA, and global health authorities across both aesthetic and medical specialties.

• Reliable Longevity: Clinical results typically become evident within 3 to 5 days, reaching peak clinical expression at 14 days, with sustained clinical efficacy lasting 3 to 4+ months.

Technical Specifications

Professional Advisory: Botox® is an authentic medical-grade pharmaceutical intended exclusively for licensed dermatologists, plastic surgeons, maxillofacial surgeons, and qualified aesthetic practitioners. Not authorized for direct consumer sales or self-administration.